BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Draijer L, Benninga M, Koot B. Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. Expert Rev Gastroenterol Hepatol 2019;13:447-61. [PMID: 30875479 DOI: 10.1080/17474124.2019.1595589] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Brunnert L, Puasa ID, Garten A, Penke M, Gaul S, Grafe N, Karlas T, Kiess W, Flemming G, Vogel M. Pediatric percentiles for transient elastography measurements - effects of age, sex, weight status and pubertal stage. Front Endocrinol 2022;13:1030809. [DOI: 10.3389/fendo.2022.1030809] [Reference Citation Analysis]
2 Yu Q, Liu Y, Hu P, Gao F, Huang G. Performance of Imaging Techniques in Non-invasive Diagnosis of Non-alcoholic Fatty Liver Disease in Children: A Systematic Review and Meta-Analysis. Front Pediatr 2022;10:837116. [DOI: 10.3389/fped.2022.837116] [Reference Citation Analysis]
3 Li J, Ha A, Rui F, Zou B, Yang H, Xue Q, Hu X, Xu Y, Henry L, Barakhat M, Stave CD, Shi J, Wu C, Cheung R, Nguyen MH. Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021. Aliment Pharmacol Ther 2022. [PMID: 35736008 DOI: 10.1111/apt.17096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee JE, Ko KO, Lim JW, Cheon EJ, Song YH, Yoon JM. Correlation between Transient Elastography (Fibroscan®) and Ultrasonographic and Computed Tomographic Grading in Pediatric Nonalcoholic Steatohepatitis. Pediatr Gastroenterol Hepatol Nutr 2022;25:240-50. [PMID: 35611380 DOI: 10.5223/pghn.2022.25.3.240] [Reference Citation Analysis]
5 Zhang JL, Du BB, Zhang DH, Li H, Kong LY, Fan GJ, Li YP, Li PC, Liang C, Wang Z, Yang LL, Hao ZY, Wu LM, Huang Z, Dong JZ, Zhang JY, Yao R, Wang SJ, Zhang YZ. OTUB1 alleviates NASH through inhibition of the TRAF6-ASK1 signaling pathways. Hepatology 2022;75:1218-34. [PMID: 34591986 DOI: 10.1002/hep.32179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Neri CR, Scapaticci S, Chiarelli F, Giannini C. Liver Steatosis: A Marker of Metabolic Risk in Children. Int J Mol Sci 2022;23:4822. [PMID: 35563210 DOI: 10.3390/ijms23094822] [Reference Citation Analysis]
7 Gao Z, Dai L, Zhang H, Cheng L. Screening Potential Drugs for the Development of NAFLD Based on Drug Perturbation Gene Set. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/7606716] [Reference Citation Analysis]
8 Wang C, Pai AK, Putra J. Paediatric non-alcoholic fatty liver disease: an approach to pathological evaluation. J Clin Pathol 2022:jclinpath-2022-208246. [PMID: 35414523 DOI: 10.1136/jclinpath-2022-208246] [Reference Citation Analysis]
9 Oses M, Cadenas-Sanchez C, Medrano M, Galbete A, Miranda-Ferrua E, Ruiz JR, Sánchez-Valverde F, Ortega FB, Cabeza R, Villanueva A, Idoate F, Labayen I. Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity. Pediatr Obes 2022;:e12917. [PMID: 35394122 DOI: 10.1111/ijpo.12917] [Reference Citation Analysis]
10 Yang A, Jung N, Kim S, Lee J. Association Between Non-invasive Diagnostic Methods of Liver Fibrosis and Type 2 Diabetes in Pediatric Patients With Non-alcoholic Fatty Liver Disease. Front Pediatr 2022;10:825141. [DOI: 10.3389/fped.2022.825141] [Reference Citation Analysis]
11 Ye X, Li J, Wang H, Wu J. Pentraxin 3 and the TyG Index as Two Novel Markers to Diagnose NAFLD in Children. Dis Markers 2021;2021:8833287. [PMID: 35059041 DOI: 10.1155/2021/8833287] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mărginean CO, Meliț LE, Săsăran MO. Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. Biomedicines 2021;9:1866. [PMID: 34944682 DOI: 10.3390/biomedicines9121866] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Yurtdaş G, Akbulut G, Baran M, Yılmaz C. The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial. Pediatr Obes 2021;:e12872. [PMID: 34881510 DOI: 10.1111/ijpo.12872] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Zhou JL, Zhao YZ, Wang SS, Chen MX, Zhou S, Chen C. RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases. Front Mol Biosci 2021;8:725308. [PMID: 34651015 DOI: 10.3389/fmolb.2021.725308] [Reference Citation Analysis]
15 Dong B, Chen Y, Lyu G, Qin R. Liver stiffness measurement as a quantitative method for liver fibrosis in children with non-alcoholic fatty liver disease: A meta-analysis. J Paediatr Child Health 2021. [PMID: 34554611 DOI: 10.1111/jpc.15751] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Mitrani R, Kohut T, Panganiban J, Carr RM. Transition of Care Model for Pediatric Patients With Nonalcoholic Fatty Liver Disease. Clin Liver Dis (Hoboken) 2021;18:30-6. [PMID: 34484702 DOI: 10.1002/cld.1093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Colucci A, Rocco MC, De Anseris AGE, Nazzaro L, Vajro P, Mandato C. Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path. Exploration of Medicine. [DOI: 10.37349/emed.2021.00051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Warnakulasuriya LS, Samaranayake DL, Adikaram AVN, Fernando MMA, Rytter E, Ciba I, Bergsten P, Forslund AH, Renuka Ruchira Silva KD, Wickramasinghe VP. Metabolic Abnormalities in a Cohort of Overweight and Obese Children in an Urban Setting of Sri Lanka. Int J Endocrinol 2021;2021:9936889. [PMID: 34285694 DOI: 10.1155/2021/9936889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Shi M, Liu P, Li J, Su Y, Zhou X, Wu C, Chen X, Zheng C. The performance of noninvasive indexes of adults in identification of nonalcoholic fatty liver disease in children. J Diabetes 2021;13:744-53. [PMID: 33576570 DOI: 10.1111/1753-0407.13169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Das A, Connell M, Khetarpal S. Digital image analysis of ultrasound images using machine learning to diagnose pediatric nonalcoholic fatty liver disease. Clin Imaging 2021;77:62-8. [PMID: 33647632 DOI: 10.1016/j.clinimag.2021.02.038] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Oses M, Medrano M, Galbete A, Arenaza L, Ruiz JR, Sánchez-Valverde F, Ortega FB, Labayen I. A sociodemographic, anthropometric and lifestyle-based prediction score for screening children with overweight and obesity for hepatic steatosis: The HEPAKID index. Pediatr Obes 2021;16:e12770. [PMID: 33403830 DOI: 10.1111/ijpo.12770] [Reference Citation Analysis]
22 Kwon Y, Jeong SJ. Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents. J Clin Med 2020;9:E3355. [PMID: 33086717 DOI: 10.3390/jcm9103355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
23 Katsagoni CN, Papachristou E, Sidossis A, Sidossis L. Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review. Nutrients 2020;12:E2864. [PMID: 32961669 DOI: 10.3390/nu12092864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
24 Małecki P, Tracz J, Łuczak M, Figlerowicz M, Mazur-Melewska K, Służewski W, Mania A. Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study. Expert Rev Proteomics 2020;17:623-32. [PMID: 32921203 DOI: 10.1080/14789450.2020.1810020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Mosca A, Panera N, Crudele A, Alisi A. Noninvasive diagnostic tools for pediatric NAFLD: where are we now? Expert Review of Gastroenterology & Hepatology 2020;14:1035-46. [DOI: 10.1080/17474124.2020.1801413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
26 Barretto JR, Boa-Sorte N, Vinhaes CL, Malta-Santos H, Rebouças-Silva J, Ramos CF, Torres-Nascimento MAS, Borges VM, Andrade BB. Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study. Nutrients 2020;12:E1650. [PMID: 32498337 DOI: 10.3390/nu12061650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Tagi VM, Samvelyan S, Chiarelli F. Metabolic syndrome in children. Minerva Pediatr 2020;72:312-25. [PMID: 32274915 DOI: 10.23736/S0026-4946.20.05834-X] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Di Sessa A, Cirillo G, Guarino S, Marzuillo P, Miraglia Del Giudice E. Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management. Pediatric Health Med Ther 2019;10:89-97. [PMID: 31692530 DOI: 10.2147/PHMT.S188989] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]